Lynx1 Capital Management as of March 31, 2023
Portfolio Holdings for Lynx1 Capital Management
Lynx1 Capital Management holds 13 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alpine Immune Sciences (ALPN) | 20.2 | $24M | 3.1M | 7.72 | |
| Cabaletta Bio (CABA) | 16.9 | $20M | 2.5M | 8.27 | |
| Merus N V (MRUS) | 16.4 | $20M | 1.1M | 18.40 | |
| Kinnate Biopharma (KNTE) | 11.5 | $14M | 2.2M | 6.25 | |
| Cymabay Therapeutics | 10.0 | $12M | 1.4M | 8.72 | |
| Pieris Pharmaceuticals (PIRS) | 5.8 | $6.9M | 7.1M | 0.98 | |
| Theseus Pharmaceuticals | 5.6 | $6.8M | 761k | 8.88 | |
| Bellus Health Com New | 5.2 | $6.2M | 867k | 7.20 | |
| Pardes Biosciences | 3.7 | $4.4M | 3.3M | 1.32 | |
| Passage Bio (PASG) | 2.7 | $3.3M | 3.4M | 0.96 | |
| Neoleukin Therapeutics | 1.4 | $1.7M | 2.4M | 0.70 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.5 | $547k | 23k | 23.79 | |
| Pharvaris N V (PHVS) | 0.2 | $211k | 26k | 8.05 |
